BR0014881A - Formulação de lipossoma de dimaleato de 6,9-bis-[(2aminoetil)-amino]benzo[gi]isoquinolina-5,10- diona - Google Patents

Formulação de lipossoma de dimaleato de 6,9-bis-[(2aminoetil)-amino]benzo[gi]isoquinolina-5,10- diona

Info

Publication number
BR0014881A
BR0014881A BR0014881-4A BR0014881A BR0014881A BR 0014881 A BR0014881 A BR 0014881A BR 0014881 A BR0014881 A BR 0014881A BR 0014881 A BR0014881 A BR 0014881A
Authority
BR
Brazil
Prior art keywords
isoquinoline
benzo
bis
amino
liposome formulation
Prior art date
Application number
BR0014881-4A
Other languages
English (en)
Inventor
Carlo Bugatti
Original Assignee
Novuspharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novuspharma Spa filed Critical Novuspharma Spa
Publication of BR0014881A publication Critical patent/BR0014881A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"FORMULAçãO DE LIPOSSOMA DE DIMALEATO DE 6,9-BIS-[(2-AMINOETIL)-AMINO]BENZO[G]ISOQUINOLINA-5,10- DIONA". Uma formulação farmacêutica de lipossoma do composto dimaleato de 6,9-bis-[(2-amoninoetil)amino]benzo[g]isoquinolina-5,10-diona, o método para a preparação e para a utilização do mesmo.
BR0014881-4A 1999-10-22 2000-10-19 Formulação de lipossoma de dimaleato de 6,9-bis-[(2aminoetil)-amino]benzo[gi]isoquinolina-5,10- diona BR0014881A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI002219A IT1315253B1 (it) 1999-10-22 1999-10-22 Preparazione liposomiale di 6,9-bis-(2-amminoetil)ammino|benzog|isochinolin-5,10-dione dimaleato
PCT/EP2000/010303 WO2001028521A2 (en) 1999-10-22 2000-10-19 Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5,10-dione dimaleate

Publications (1)

Publication Number Publication Date
BR0014881A true BR0014881A (pt) 2002-06-11

Family

ID=11383836

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014881-4A BR0014881A (pt) 1999-10-22 2000-10-19 Formulação de lipossoma de dimaleato de 6,9-bis-[(2aminoetil)-amino]benzo[gi]isoquinolina-5,10- diona

Country Status (23)

Country Link
US (1) US7449197B2 (pt)
EP (1) EP1221940B1 (pt)
JP (1) JP2003512313A (pt)
KR (1) KR20020063880A (pt)
CN (1) CN1164261C (pt)
AT (1) ATE335468T1 (pt)
AU (1) AU772339B2 (pt)
BR (1) BR0014881A (pt)
CA (1) CA2386143A1 (pt)
CZ (1) CZ20021388A3 (pt)
DE (1) DE60029979T2 (pt)
EA (1) EA004477B1 (pt)
ES (1) ES2269200T3 (pt)
HU (1) HUP0203473A3 (pt)
IL (2) IL149212A0 (pt)
IT (1) IT1315253B1 (pt)
MX (1) MXPA02003939A (pt)
NO (1) NO20021867L (pt)
NZ (1) NZ518005A (pt)
PL (1) PL197412B1 (pt)
SK (1) SK284247B6 (pt)
WO (1) WO2001028521A2 (pt)
ZA (1) ZA200203128B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2353593A1 (en) * 1998-12-18 2000-06-22 Hadasit Medical Research Services & Development Ltd. Method of administering a compound to multi-drug resistant cells
ITMI20021040A1 (it) 2002-05-16 2003-11-17 Novuspharma Spa Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale
CN1305881C (zh) * 2004-08-13 2007-03-21 河南工业大学 磷脂酰胆碱的制备方法
CN103479578B (zh) * 2012-06-14 2016-08-03 沈阳药科大学 一种马来酸匹杉琼的脂质体制剂及其制备工艺
CN105596295B (zh) * 2016-01-25 2018-03-16 北京博恩特药业有限公司 马来酸匹杉琼脂质体及其制备方法
CN105997896B (zh) * 2016-05-28 2019-07-05 长沙秋点兵信息科技有限公司 治疗非霍奇金淋巴瘤的注射用冻干粉及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797285A (en) * 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
JPS6442418A (en) * 1985-12-06 1989-02-14 Yissum Res Dev Co Liposome/anthraquinone drug composition and therapy therewith
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
ES2072223B1 (es) * 1993-11-25 1996-03-16 Lipotec Sa Liposomas encapsulando doxorubicina.
CA2184834A1 (en) * 1994-03-11 1995-09-14 Yoshiyuki Mori Liposome preparation
US5587382A (en) * 1994-03-28 1996-12-24 Boehringer Mannheim Italia, Spa 6,9-bis[(2-aminoethyl) amino]benzo [g]isoquinoline-5,10- dione dimaleate; an aza-anthracenedione with reduced cardiotoxicity
US5506232A (en) * 1994-03-28 1996-04-09 Boehringer Mannheim Italia S.P.A. 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its dimaleate salt
WO1999011242A1 (en) * 1997-09-04 1999-03-11 Biozone Laboratories, Inc. Oral liposomal delivery system

Also Published As

Publication number Publication date
NZ518005A (en) 2003-10-31
PL197412B1 (pl) 2008-03-31
ITMI992219A1 (it) 2001-04-22
IT1315253B1 (it) 2003-02-03
WO2001028521A3 (en) 2002-04-25
CZ20021388A3 (cs) 2002-08-14
DE60029979T2 (de) 2007-02-22
US20060078607A1 (en) 2006-04-13
EA200200389A1 (ru) 2002-08-29
HUP0203473A2 (hu) 2003-02-28
SK284247B6 (sk) 2004-12-01
PL354610A1 (en) 2004-02-09
CA2386143A1 (en) 2001-04-26
EP1221940B1 (en) 2006-08-09
CN1164261C (zh) 2004-09-01
ZA200203128B (en) 2003-06-05
EP1221940A2 (en) 2002-07-17
MXPA02003939A (es) 2004-06-25
NO20021867D0 (no) 2002-04-19
SK5382002A3 (en) 2002-09-10
KR20020063880A (ko) 2002-08-05
JP2003512313A (ja) 2003-04-02
IL149212A0 (en) 2002-11-10
IL149212A (en) 2006-12-10
ATE335468T1 (de) 2006-09-15
US7449197B2 (en) 2008-11-11
DE60029979D1 (de) 2006-09-21
EA004477B1 (ru) 2004-04-29
AU772339B2 (en) 2004-04-22
AU1514601A (en) 2001-04-30
CN1382039A (zh) 2002-11-27
HUP0203473A3 (en) 2003-12-29
WO2001028521A2 (en) 2001-04-26
NO20021867L (no) 2002-04-19
ES2269200T3 (es) 2007-04-01

Similar Documents

Publication Publication Date Title
YU84703A (sh) Oralni rastvor aripiprazola
MY117971A (en) Denaturants for sympathomimetic amine salts
AU2002255077A1 (en) Derivatives of N-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
IL192233A0 (en) Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a subsituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing them
WO1999054286A3 (en) Btk inhibitors and methods for their identification and use
NO20043663L (no) Bicykliske aminosyrer som farmasoytiske midler
DK0971717T3 (da) Cytotoksiske aminosukker- og relaterede sukkerderivater af indolopyrrolocarbazoler
NO996208D0 (no) Nye 2-(iminometyl)amino- fenylderivater, fremstilling og blandinger derav, samt anvendelse som legemiddel
PT1185253E (pt) Forma de administracao oral para administracao de uma combinacao fixa de tramadol e diclofenac
BR0211063A (pt) Sais de derivados anticonvulsivantes
ATE287264T1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
NO20006646L (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
PT1165081E (pt) Processo para a preparacao de preparacoes farmaceuticas cintendo tolperisona, para administracao oral
BR9912010A (pt) Polimorfo de um produto farmacêutico
BR0014881A (pt) Formulação de lipossoma de dimaleato de 6,9-bis-[(2aminoetil)-amino]benzo[gi]isoquinolina-5,10- diona
PT1395231E (pt) Preparacao para a remocao de material queratinoso anormal
MA24775A1 (fr) Sels de cetoacides et de derives amines, et leur utilisation pour la preparation de medicaments
IS6087A (is) N-(2-fenýl-4-amínó-bútýl)-1-naftamíð sem virka á móti taugakínín-1 viðtaka
WO2003004517A3 (en) Peyers's patch and/or m-celle targeting ligands
BR9812085A (pt) "método para a sìntese de derivados de quinolina"
HUP0401773A3 (en) Use of [(2-amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkanacid derivatives for the preparation pharmaceutical compositions usable for treatment of pain
BR9814495A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo
AU4770400A (en) Fused polycyclic amino acids as pharmaceutical agents
MY128529A (en) Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8,13,24 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.